TP53 and malignant colon neoplasm: This association between basal-like tumors and L1 overexpression was partially confirmed by McKerrow and colleagues [46], who reported an increased L1 expression in TP53 mutated tumors, recently confirmed in breast, ovarian and colon cancers [46].